TAK-029
TAK-029 is a potent GP IIb/IIIa antagonist. TAK-029 has potent antithrombotic effects with bleeding time (BT) prolongation in arterial thrombosis models. TAK-029 can be used for the research of various arterial thrombotic diseases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 176655-58-6
- Formule: C19H23N5O7
- Masse moléculaire:433.42
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
In dogs, TAK-029 (30-100 μg/kg, iv) inhibited ADP-induced platelet aggregation in vitro[1].
In monkeys, TAK-029 (10-30 μg/kg, iv) inhibited ADP-induced platelet aggregation in vitro and prolonged BT[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 176655-58-6
-
Masse moléculaire 433.42
-
Formule C19H23N5O7
-
SMILES
O=C(CNC(C1=CC=C(C(N)=N)C=C1)=O)N([C@H]2CC(OC)=O)CCN(CC(O)=O)C2=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)